INSIGHTS FROM LEADERSHIP
Patient Focused Drug Development
Patient insight doesn’t just inform our work—it drives it. Read about our approach to patient driven innovation and development from Stephanie Kallay, Director of Patient Advocacy.
Celebrating Women’s Leadership: Crinetics’ Commitment to Scientific and Strategic Excellence
In honor of Women’s History Month, Chief Corporate Affairs Officer Jacqui Kirby reflects on the inspiring female leaders who have shaped the pharmaceutical industry.
Acromegaly Awareness Day: Our Support to the Community Today and Beyond
November 1 is Acromegaly Awareness Day—an important moment in time to raise awareness and provide support for those impacted by it. Hear Dana Pizzuti, Chief Medical and Development Officer, reflect on the significant progress we have made toward developing a new generation of acromegaly treatment.
FOCUS ON SCIENCE
Understanding the Role of IGF-1 in Managing Acromegaly
At AACE 2025, new research sponsored by Crinetics showed just how important IGF-1 is—not just for diagnosis, but for tracking the impact of treatment. In this article, hear from Dr. Alan Krasner where he discusses the central role of IGF-1 in managing acromegaly.